Drugs / LCMUFA-rich saury oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03043365 | Jun 2017 → May 2019 | hypercholesterolemia, autosomal dominant, 3, lipoprotein types--Lt system | National Heart, Lung, and Blood Institute (NHLBI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LCMUFA-rich saury oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03043365 ↗ |
| Modality | Other / unclassified | “fish oil supplement produced from Saury fish (rich in LCMUFA)” NCT03043365 ↗ |